A U.S. biotechnology company began injecting a coronavirus vaccine candidate into people in Australia with hopes of releasing a proven vaccine this ...
News
- What you need to know today about the virus outbreak
- Sanofi adds firepower in exiting $13 billion Regeneron stake
... fast-growing areas, is sparking speculation he'll hunt for more targets following a deal in December to buy biotech company Synthorx for $2.5 billion.
- Why COVID-19 immunity passports may violate US law
As a law professor who has written about legal issues raised by new biotechnologies, I'm concerned about the potential legal and ethical ramifications ...
- Risks complicate reopenings as WHO warns 1st wave not over
Tests by a U.S. biotechnology company, Novavax, have begun in Australia with hopes of releasing a proven vaccine this year. A Novavax executive ...
- Asia Today: Philippines trying to ease quarantine congestion
VACCINE TRIAL BEGINS: U.S. biotechnology company Novavax began injecting a coronavirus vaccine candidate into people in Australia with hopes ...